Logo image of OLPX

OLAPLEX HOLDINGS INC (OLPX) Stock Fundamental Analysis

USA - NASDAQ:OLPX - US6793691089 - Common Stock

1.3 USD
+0.02 (+1.56%)
Last: 10/3/2025, 8:00:02 PM
1.3 USD
0 (0%)
After Hours: 10/3/2025, 8:00:02 PM
Fundamental Rating

5

Overall OLPX gets a fundamental rating of 5 out of 10. We evaluated OLPX against 36 industry peers in the Personal Care Products industry. OLPX has an excellent financial health rating, but there are some minor concerns on its profitability. OLPX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

OLPX had positive earnings in the past year.
OLPX had a positive operating cash flow in the past year.
In the past 5 years OLPX has always been profitable.
OLPX had a positive operating cash flow in each of the past 5 years.
OLPX Yearly Net Income VS EBIT VS OCF VS FCFOLPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

OLPX's Return On Assets of -0.08% is in line compared to the rest of the industry. OLPX outperforms 44.44% of its industry peers.
The Return On Equity of OLPX (-0.15%) is comparable to the rest of the industry.
The Return On Invested Capital of OLPX (2.54%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for OLPX is below the industry average of 12.97%.
The 3 year average ROIC (8.40%) for OLPX is well above the current ROIC(2.54%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.08%
ROE -0.15%
ROIC 2.54%
ROA(3y)6.34%
ROA(5y)7.22%
ROE(3y)13.59%
ROE(5y)18.06%
ROIC(3y)8.4%
ROIC(5y)9.93%
OLPX Yearly ROA, ROE, ROICOLPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 100 200 300 400

1.3 Margins

OLPX's Profit Margin has declined in the last couple of years.
OLPX's Operating Margin of 10.97% is fine compared to the rest of the industry. OLPX outperforms 72.22% of its industry peers.
In the last couple of years the Operating Margin of OLPX has declined.
Looking at the Gross Margin, with a value of 70.81%, OLPX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
OLPX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.97%
PM (TTM) N/A
GM 70.81%
OM growth 3Y-33.32%
OM growth 5Y-23.34%
PM growth 3Y-49.98%
PM growth 5Y-35.41%
GM growth 3Y-3.57%
GM growth 5Y-2.1%
OLPX Yearly Profit, Operating, Gross MarginsOLPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

OLPX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, OLPX has more shares outstanding
Compared to 5 years ago, OLPX has more shares outstanding
OLPX has a better debt/assets ratio than last year.
OLPX Yearly Shares OutstandingOLPX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
OLPX Yearly Total Debt VS Total AssetsOLPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

OLPX has an Altman-Z score of 1.95. This is not the best score and indicates that OLPX is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.95, OLPX is in line with its industry, outperforming 41.67% of the companies in the same industry.
The Debt to FCF ratio of OLPX is 3.63, which is a good value as it means it would take OLPX, 3.63 years of fcf income to pay off all of its debts.
OLPX has a Debt to FCF ratio of 3.63. This is in the better half of the industry: OLPX outperforms 77.78% of its industry peers.
A Debt/Equity ratio of 0.40 indicates that OLPX is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.40, OLPX perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 3.63
Altman-Z 1.95
ROIC/WACC0.32
WACC8%
OLPX Yearly LT Debt VS Equity VS FCFOLPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

OLPX has a Current Ratio of 3.86. This indicates that OLPX is financially healthy and has no problem in meeting its short term obligations.
OLPX has a Current ratio of 3.86. This is amongst the best in the industry. OLPX outperforms 83.33% of its industry peers.
A Quick Ratio of 3.20 indicates that OLPX has no problem at all paying its short term obligations.
OLPX has a better Quick ratio (3.20) than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 3.86
Quick Ratio 3.2
OLPX Yearly Current Assets VS Current LiabilitesOLPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

The earnings per share for OLPX have decreased strongly by -42.86% in the last year.
OLPX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.10% yearly.
The Revenue has decreased by -3.44% in the past year.
OLPX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.32% yearly.
EPS 1Y (TTM)-42.86%
EPS 3Y-54.93%
EPS 5Y-20.1%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-3.44%
Revenue growth 3Y-10.94%
Revenue growth 5Y23.32%
Sales Q2Q%2.25%

3.2 Future

Based on estimates for the next years, OLPX will show a decrease in Earnings Per Share. The EPS will decrease by -4.14% on average per year.
OLPX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 29.95% yearly.
EPS Next Y-30.45%
EPS Next 2Y-11.97%
EPS Next 3Y-4.14%
EPS Next 5YN/A
Revenue Next Year2.86%
Revenue Next 2Y2.86%
Revenue Next 3Y2.92%
Revenue Next 5Y29.95%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OLPX Yearly Revenue VS EstimatesOLPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
OLPX Yearly EPS VS EstimatesOLPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.25, OLPX is valued correctly.
Based on the Price/Earnings ratio, OLPX is valued a bit cheaper than 77.78% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.86. OLPX is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 15.25, OLPX is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of OLPX indicates a somewhat cheap valuation: OLPX is cheaper than 72.22% of the companies listed in the same industry.
OLPX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.32, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.25
Fwd PE 15.25
OLPX Price Earnings VS Forward Price EarningsOLPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OLPX is valued a bit cheaper than the industry average as 72.22% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, OLPX is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.93
EV/EBITDA 9.19
OLPX Per share dataOLPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A cheap valuation may be justified as OLPX's earnings are expected to decrease with -4.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.97%
EPS Next 3Y-4.14%

0

5. Dividend

5.1 Amount

OLPX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OLAPLEX HOLDINGS INC

NASDAQ:OLPX (10/3/2025, 8:00:02 PM)

After market: 1.3 0 (0%)

1.3

+0.02 (+1.56%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners14.03%
Inst Owner Change0.01%
Ins Owners0.65%
Ins Owner Change7.5%
Market Cap867.20M
Analysts52.86
Price Target2.1 (61.54%)
Short Float %7.54%
Short Ratio10.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.18%
Min EPS beat(2)-32.11%
Max EPS beat(2)60.46%
EPS beat(4)2
Avg EPS beat(4)22%
Min EPS beat(4)-32.11%
Max EPS beat(4)69.03%
EPS beat(8)5
Avg EPS beat(8)16.36%
EPS beat(12)8
Avg EPS beat(12)10.16%
EPS beat(16)12
Avg EPS beat(16)10.46%
Revenue beat(2)2
Avg Revenue beat(2)2.62%
Min Revenue beat(2)1.35%
Max Revenue beat(2)3.89%
Revenue beat(4)3
Avg Revenue beat(4)2.54%
Min Revenue beat(4)-7.47%
Max Revenue beat(4)12.38%
Revenue beat(8)6
Avg Revenue beat(8)1.96%
Revenue beat(12)7
Avg Revenue beat(12)-0.92%
Revenue beat(16)11
Avg Revenue beat(16)0.66%
PT rev (1m)3.6%
PT rev (3m)-0.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.5%
EPS NY rev (1m)25%
EPS NY rev (3m)14.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.65%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)0.48%
Valuation
Industry RankSector Rank
PE 16.25
Fwd PE 15.25
P/S 2.05
P/FCF 8.93
P/OCF 8.58
P/B 0.99
P/tB N/A
EV/EBITDA 9.19
EPS(TTM)0.08
EY6.15%
EPS(NY)0.09
Fwd EY6.56%
FCF(TTM)0.15
FCFY11.19%
OCF(TTM)0.15
OCFY11.66%
SpS0.63
BVpS1.31
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.08%
ROE -0.15%
ROCE 3.32%
ROIC 2.54%
ROICexc 3.2%
ROICexgc 54.14%
OM 10.97%
PM (TTM) N/A
GM 70.81%
FCFM 22.94%
ROA(3y)6.34%
ROA(5y)7.22%
ROE(3y)13.59%
ROE(5y)18.06%
ROIC(3y)8.4%
ROIC(5y)9.93%
ROICexc(3y)11%
ROICexc(5y)12.02%
ROICexgc(3y)125.03%
ROICexgc(5y)244.84%
ROCE(3y)11%
ROCE(5y)12.99%
ROICexcg growth 3Y-27.54%
ROICexcg growth 5Y-25.57%
ROICexc growth 3Y-37.52%
ROICexc growth 5Y-59.98%
OM growth 3Y-33.32%
OM growth 5Y-23.34%
PM growth 3Y-49.98%
PM growth 5Y-35.41%
GM growth 3Y-3.57%
GM growth 5Y-2.1%
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 3.63
Debt/EBITDA 3.53
Cap/Depr 7.58%
Cap/Sales 0.95%
Interest Coverage 0.85
Cash Conversion 101.42%
Profit Quality N/A
Current Ratio 3.86
Quick Ratio 3.2
Altman-Z 1.95
F-Score5
WACC8%
ROIC/WACC0.32
Cap/Depr(3y)7.27%
Cap/Depr(5y)5.1%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.53%
Profit Quality(3y)364.56%
Profit Quality(5y)302.34%
High Growth Momentum
Growth
EPS 1Y (TTM)-42.86%
EPS 3Y-54.93%
EPS 5Y-20.1%
EPS Q2Q%-33.33%
EPS Next Y-30.45%
EPS Next 2Y-11.97%
EPS Next 3Y-4.14%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.44%
Revenue growth 3Y-10.94%
Revenue growth 5Y23.32%
Sales Q2Q%2.25%
Revenue Next Year2.86%
Revenue Next 2Y2.86%
Revenue Next 3Y2.92%
Revenue Next 5Y29.95%
EBIT growth 1Y-49.69%
EBIT growth 3Y-40.62%
EBIT growth 5Y-5.47%
EBIT Next Year-15.03%
EBIT Next 3Y-1.94%
EBIT Next 5YN/A
FCF growth 1Y-51.1%
FCF growth 3Y-11.33%
FCF growth 5Y21.31%
OCF growth 1Y-50.02%
OCF growth 3Y-10.57%
OCF growth 5Y22.16%